CRISPR Discoverer Joins Max Planck Institute
This article was originally published in Scrip
Executive Summary
Emmanuelle Charpentier, who was named one of the "most influential scientists" by Time magazine when she co-discovered of CRISPR-Cas9, is joining the Max Planck Institute for Infection Biology, Berlin, in Oct. 2015, as a director. The French molecular biologist will be tasked with setting up a new department at the institute, which will explore the regulatory processes in bacterial infectious diseases.